SAVA — Cassava Sciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Cassava Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	93.5	233	201	121	129
Net Total Accounts Receivable
Net Total Receivables	—	—	—	0.962	0.947
Prepaid Expenses
Total Other Current Assets
Total Current Assets	94	244	211	130	137
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.306	20.8	23	21.9	21
Net Intangible Assets
Other Long Term Assets
Total Assets	94.3	267	235	152	158
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	1.86	12.5	7.06	14.2	11.8
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.1	12.9	7.29	14.2	11.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	92.2	254	228	137	146
Total Liabilities & Shareholders' Equity	94.3	267	235	152	158
Total Common Shares Outstanding